Effect of the endothelin type A–selective endothelin receptor antagonist ambrisentan on digital ulcers in patients with systemic sclerosis: Results of a prospective pilot study - 16/07/14
Doi : 10.1016/j.jaad.2014.04.028
Lorinda Chung, MD, MS a, b, c, ⁎ 
, Katharine Ball, MD a, Aaliya Yaqub, MD c, Bharathi Lingala, PhD a, c, David Fiorentino, MD, PhD a
, Katharine Ball, MD a, Aaliya Yaqub, MD c, Bharathi Lingala, PhD a, c, David Fiorentino, MD, PhD a a Department of Dermatology, Stanford University School of Medicine, Stanford, California
b Division of Rheumatology, Palo Alto Veterans Affairs Health Care System, Palo Alto, California
c Department of Medicine, Division of Rheumatology, Stanford University School of Medicine, Stanford, California
∗Reprint requests: Lorinda Chung, MD, MS, 3801 Miranda Ave, Palo Alto VA Health Care System, Palo Alto, CA 94304
| Supported by Gilead Sciences, who provided study drug and financial support for the study. Gilead Sciences was not involved in the writing, study design, collection, analysis, or interpretation of the data. Gilead Sciences reviewed the submitted manuscript and agreed to submit it for publication. Dr Chung receives funding support from the Scleroderma Research Foundation. |
|
| Dr Chung has received honoraria for serving on the advisory board and speaking engagements from Gilead Sciences and for consulting services and speaking engagements from Actelion. No other conflicts of interest were declared. |
© 2014
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 71 - N° 2
P. 400-401 - août 2014 Retour au numéro
Article précédent
- Eruptive disseminated porokeratosis: A new classification system
- Ilya Shoimer, Lynne H. Robertson, Gregory Storwick, Richard M. Haber
- Challenges in measuring outcomes: Size assessment of an individual cutaneous lesion
- Lauren Okon, Victoria P. Werth
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?